companydata.dkRenescience A/S: Financial statements 2019
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -23,169,000 and a net result of DKK -18,126,000 compared with DKK -19,092,000 the year before. Equity amounted to DKK 44,568,000. The solvency ratio was 89%.
- Gross Profit
- -23,169,000 kr.
- Profit/Loss
- -18,126,000 kr.
- Equity
- 44,568,000 kr.
- Total Assets
- 50,085,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -23.2 mio. | -18.1 mio. | 44.6 mio. | - |
| 2018 | - | -24.3 mio. | -19.1 mio. | 62.7 mio. | - |
| 2017 | - | -9.7 mio. | -7.8 mio. | 81.8 mio. | - |
| 2016 | - | -37.1 mio. | -29.5 mio. | 89.5 mio. | - |
| 2015 | - | -56 mio. | -43.2 mio. | 24.1 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
As of October 31, 2019, Morten Hultberg Buchgreitz has joined the board of directors of Renescience A/S.
As of October 31, 2019, Ole Thomsen has joined the board of directors of Renescience A/S.
As of October 31, 2019, Niels Henriksen has left the board of directors of Renescience A/S.
As of October 31, 2019, Thomas Dalsgaard has left the board of directors of Renescience A/S.
Renescience A/S has published its annual report for 2018. Gross profit came to DKK -24,267,000, and the net result was DKK -19,092,000.
As of March 20, 2019, Hanne Risbjerg Sørensen is registered as director of Renescience A/S.
As of March 20, 2019, Hannes Reuter has stepped down as director of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.